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Abstract 
Erythrocytes and spectrin-free DMPC-induced vesicles released from the cells were incubated for 3 weeks at 6°C under conditions of 
metabolic ATP-depletion. Phosphatidylserine (PS) asymmetry was monitored uring this period by use of the prothrombinase assay. 
Prothrombinase activities measured at the beginning of the incubation period indicated that approximately 0.06% of PS was located at the 
outer layer of the red cell membrane, whereas in DMPC-induced vesicles approximately 1.5% the PS was exposed on the outside. After 
completion of the incubation period PS exposure on the outside of red cells and vesicles was increased by no more than 5-fold. On the 
other hand, with vesicles prepared with a significantly increased (4-fold) ATP-content o sustain translocase activity, the incubation 
process resulted in a surprisingly high (20-fold) increase of PS exposure. With vanadate, an inhibitor of the aminophospholipid 
translocase, included in the incubation medium, the redistribution of PS was even more pronounced. These observations indicate that PS 
asymmetry in spectrin-free vesicles can not be directly correlated to either ATP content or translocase activity and suggest that besides the 
aminophospholipid translocase and the membrane skeleton, other mechanisms must be involved in maintaining phospholipid asymmetry. 
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1. Introduction 
The phospholipids in the plasma membrane of many 
eukaryotic ells are distributed asymmetrically across both 
halves of the bilayer. In red blood cells, almost all 
phosphatidylserine (PS) and the major part of phospha- 
tidylethanolamine is located in the cytoplasmic half of the 
bilayer, whereas the choline-containing phospholipids are 
mainly present at the outside of the membrane [ 1,2]. Since 
the transbilayer movement of some phospholipids is rela- 
tively fast compared to the life-span of the red cell, there 
must be mechanisms available that can counteract long- 
term phospholipid randomization. 
It is widely accepted that an ATP-dependent 
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aminophospholipid translocase is capable of transporting 
exogenously added aminophospholipids from the outer to 
the inner monolayer of the membrane (for review, see [3]). 
However, it is not clear whether this translocase is alone 
responsible for generating and maintaining phospholipid 
asymmetry. It has been suggested that it serves rather as a 
repair mechanism [4], whereas other systems, such as the 
membrane skeleton [5], play part in retaining PS at the 
inner monolayer. Recent studies however, have shown that 
red cell membrane systems that lack (parts of) the mem- 
brane skeleton can still remain asymmetric [6-8]. 
Several investigations have demonstrated that in the 
erythrocyte membrane phospholipid asymmetry is not im- 
mediately lost upon prolonged inactivation of the 
aminophospholipid translocase, for example due to ATP 
depletion [9-12]. However, in these studies it could not be 
excluded that asymmetry was maintained ue to the pres- 
ence of the membrane skeleton. So far, no investigations 
have elucidated to what extent phospholipid asymmetry 
can be sustained for a prolonged time period in a mem- 
brane system where aminophospholipid translocase activ- 
ity is abolished, and an intact membrane skeleton is miss- 
ing. 
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DMPC-induced membrane vesicles from red blood cells 
have been used successfully in studies concerning 
phospholipid asymmetry. These vesicles contain intrinsic 
membrane proteins but are completely devoid of spectrin 
and depleted in other elements of the membrane skeleton 
[13,14]. With exception of the additional DMPC, their 
phospholipid composition is almost identical to the one 
observed in intact erythrocytes. It has been shown that the 
vesicles contain an ATP-dependent aminophospholipid 
translocase activity [15], and that the steady-state phospho- 
lipid distribution is still highly asymmetric directly after 
preparation [8]. 
In the present study, the prothrombinase assay was used 
as a very sensitive technique to examine the orientation of 
PS in the membranes of erythrocytes and DMPC-induced 
vesicles in the course of metabolic ATP-depletion. The 
investigations were performed on two types of DMPC-in- 
duced vesicles with different ATP-levels to obtain more 
information on the contribution of the translocase to main- 
taining asymmetry in the vesicles. Vanadate, which can act 
as an inhibitor of P-type ATPases, and has been shown to 
inhibit the aminophospholipid translocase [ 16], was used to 
further inhibit the translocase activity. 
The results suggest that, besides the aminophospholipid 
translocase and possibly the membrane skeleton, other 
mechanisms must be considered to contribute to maintain- 
ing phospholipid asymmetry. 
Part of this work was presented at the FEBS Special 
Meeting of Biological Membranes in Helsinki, 1994. 
2. Materials and methods 
with 3 nM factor Xa, 6 nM factor Va, and 4 /~M pro- 
thrombin (final concentrations) in a buffer containing 10 
mM TRIS-HC1, 136 mM NaC1, 1.6 mM KC1, 4 mM CaC12 
and 0.5 mg/ml HSA, pH 7.9. After a 2 min preincubation 
in presence of factor Va and factor Xa, prothrombin was 
added and at timed intervals, aliquots of 25 /xl were 
transferred to 1 ml of a buffer containing 2 mM EDTA to 
stop the reaction. The amount of thrombin formed was 
assessed using the chromogenic substrate $2238. 
The prothrombinase activity was always expressed per 
total phospholipid concentration. For a rough quantifica- 
tion of the amount of PS exposed on the membrane 
surface, the prothrombinase activities measured in pres- 
ence of sonicated cell and vesicle suspensions, as well as 
sonicated lipid extracts of both systems were compared. 
By correlation of the measured activities in presence of 
these systems [8] to the theoretical fraction of PS that was 
exposed on the surface of these systems, it could be 
estimated that under our conditions 100% PS availability 
on a phospholipid surface would result in a prothrombi- 
nase activity in the range of 1300-2400 nM thrombin/min 
•/zM PL. Additionally, completely hemolysed (but not 
sonicated) cells were obtained by diluting the cells 20 
times with distilled water before the assay• The prothrom- 
binase activity in presence of these membranes was found 
to be 85 + 19 nM thrombin/min •/xM PL. 
2.3. ATP-content 
The ATP-content of cells and DMPC-induced vesicles 
was assessed using a luciferin-luciferase bioluminescence 
assay after TCA precipitation as described earlier [15]. 
2.1. Materials 
Purified prothrombin, factor Va and factor Xa were 
supplied by Dr. R. Wagenvoord, University of Limburg, 
the Netherlands. The chromogenic substrate $2238 was 
obtained from Chromogenix AB, MiSlndal, Sweden. 
Leupeptine was obtained from Boehringer Mannheim, 
and neuraminidase from Sigma (E.C. 3.2.1.18, type X). 
All other reagents used were obtained either from 
Merck, Fluka or Sigma, and of the highest grade available. 
2.2. Prothrombinase assay 
The prothrombinase assay was used to obtain semiquan- 
titative information on the orientation of PS in cell and 
vesicle membranes. The assay, originally designed by Bev- 
ers et al. [17], was performed as described earlier [8]. 
Briefly, cell suspensions (final phospholipid concentrations 
1 to 25 /xM, dependent on activity) or vesicle suspensions 
(final phospholipid concentrations 0.2 to 3 /~M) that had 
been diluted freshly with buffer A (10 mM Hepes, 144 
mM NaC1, pH 7.4), or buffer as a blank, were assayed 
2.4. Vesicle integrity 
Adenylate kinase activity was determined as described 
by Beleznay et al. [15]. Vesicle integrity was expressed as 
the percent ratio of the enzyme activities measured in 
absence and presence of Triton X-100. 
2.5. Acetylcholinesterase activity 
ACHE, used as a membrane marker to characterize 
vesicle concentration, was determined according to Ell- 
mann et al. [18]. 
2.6. Phospholipid quantification 
Lipids were extracted from an aliquot of each cell 
suspension according to Rose and Oklander [19] and from 
0.5 ml of the vesicle stock suspensions using the method 
of Bligh and Dyer [20]. Total phospholipid was quantified 
by determination of the phosphorus content according to 
Rouser et al. [21]. 
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2.7. Erythrocyte storage 
Concentrated erythrocytes in standard anticoagulant 
buffer were obtained from the ZLB Central Laboratory, 
Swiss Red Cross Blood Transfusion Service (Bern, 
Switzerland). One volume of cells was washed 3 times in 
sterile tubes with 2 volumes of sterile filtered buffer B (15 
mM sodium phosphate, 2 mM adenine, 45 mM deoxyglu- 
cose, 40 mM mannitol and 100 mM NaC1, pH 7.4) by 
centrifugation at 1000 X g for 5 min and subsequent re- 
moval of the supernatant and remaining buffy coat. The 
cells were resuspended to approximately 20% hematocrit 
in buffer B, and stored at 6°C for up to 3 weeks. 
At given times, an aliquot of cells was washed at least 5 
times with 2 volumes of buffer A by centrifugation at 
1000 X g for 5 min and aspiration of the supernatant to
remove damaged cells. The cells were resuspended in 
buffer A at the appropriate concentration (20 to 500 /xM 
total phospholipid) and immediately used in the prothrom- 
binase assay. To obtain information on the fragility of the 
cells, an aliquot of the suspension was taken after gentle 
re-homogenization, centrifuged at 1000 X g, and the super- 
natant was sampled to determine hemolysis, by comparing 
the hemoglobin concentration (measured at 414 nm) to an 
equivalent amount of cell hemolysate. Samples were also 
taken for the determinations of the total ATP and 
hemoglobin contents of the cells. 
Alternatively, cells were washed and stored in buffer B 
containing 2.5 mM sodium orthovanadate. In this case, at 
each given time, 2.5 mM vanadate was also added to 
buffer A, to wash and resuspend the cells. Otherwise the 
procedure was the same as with the storage in absence of 
vanadate. The presence of vanadate did not affect the 
prothrombinase activity (data not shown). 
2.8. Vesicle storage 
Membrane vesicles were released both from regular 
fresh erythrocytes (Iow-ATP vesicles) and from cells with 
3 to 4 times increased ATP-levels (high-ATP vesicles) [15] 
by incubation with DMPC as described earlier [13]. The 
vesicles were purified on a Sephacryl S-1000 column [15], 
resuspended in buffer A at a concentration corresponding 
to an amount of 10 IU AChE/ml suspension (correspond- 
ing to 2 mM total PL) and kept in this buffer at 6°C. 
Alternatively, vesicles were stored in buffer A containing 
2.5 mM sodium orthovanadate. At timed intervals as indi- 
cated in the figures, aliquots were diluted 50 to 800 times 
to obtain the appropriate phospholipid concentrations 
(verified by comparing the AChE-activities in the stock 
solution and the assay samples), and immediately used in 
the prothrombinase assay. Samples were taken for determi- 
nations of ATP-content, and vesicle integrity was assessed 
using the adenylate kinase assay. 
When the fraction of opened vesicles exceeded 5%, the 
vesicles (in a total volume of 1 ml) were subjected to 
purification on a 4 ml Sephacryl S-1000 column equili- 
brated in buffer A, by which most of the leaky vesicles 
could be removed. 
2.9. Neuraminidase treatment of erythrocytes 
An aliquot (0.5 ml) of packed fresh red blood cells was 
carefully suspended in 2 volumes of buffer A containing 
0.5 mg/1 leupeptine and 0.1 IU/ml neuraminidase, and 
incubated for 1 h at 37°C. The suspensions were cen- 
trifuged for 4 min at 1000 X g and the supernatant was 
used for determinations of sialic acid release and hemoly- 
sis. All further manipulations were performed at 4°C. The 
cell pellets were washed 3 times with 1 ml buffer A 
containing 0.5 mg/1 leupeptine. A 200 /zl aliquot of the 
washed cells was used to prepare white ghosts for sialic 
acid determination. The remaining cells were washed once 
again in buffer A and assayed for prothrombinase activity 
as described for untreated cells. 
The sialic acid determination was performed with 30/zl 
aliquots of packed ghosts and 25/zl aliquots of supernatant 
according to Skoza and Mohos [22]. Sialic acid release was 
more than 85% without significant hemolysis (less than 
0.5%) of the cells. 
2.10. SDS-polyacrylamide g l electrophoresis 
Open white ghosts were prepared by hypotonic lysis 
according to Gratzer [23] and stored at -80°C. Vesicle 
membranes were obtained by incubation of an aliquot of 
DMPC-induced vesicles (at a concentration of 10 IU 
AChE/ml) with an equal volume of 3 mg/ml digitonin 
(Sigma) for 15 min at room temperature. The suspensions 
were diluted 4 times with buffer A containing 0.5 mg/1 
leupeptine and centrifuged at 30 000 X g for 10 min. The 
pellet was washed with buffer A with leupeptine and 
subsequently delipidified by a 2-phase lipid extraction as 
described by Bligh and Dyer [20], with the proteins found 
at the interface of the phases. The dry protein pellets were 
stored at - 80°C. 
Packed ghosts, vesicle suspensions or vesicle membrane 
extracts were dissolved in a buffer containing 2% SDS and 
10% fl-mercaptoethanol and applied to a SDS-polyacryl- 
amide gradient gel containing 8 to 15% polyacrylamide. 
Electrophoresis was performed according to Laemmli [24] 
and the gel was stained with Coomassie Blue. 
3. Results 
3.1. Exposure of PS on cell and vesicle surfaces 
In presence of freshly prepared DMPC-induced vesicles 
a higher prothrombinase activity was obtained than in 
presence of erythrocytes ( ee Table 1). An estimation of 
the amount of PS exposed on the outer monolayer could be 
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obtained by comparing the prothrombinase activity to the 
activity in presence of sonicated membrane systems as 
described in Section 2. This revealed that approximately 
1.5% PS was exposed on the outside of both types of 
vesicles, and 0.06% on the outside of intact cells. Removal 
of sialic acid residues from the cells by treatment with 
neuraminidase did not result in a significantly increased 
prothrombinase activity (Table 1). 
3.2. Erythrocyte storage 
During storage at 6°C in presence of deoxyglucose, the 
cells were depleted of ATP by more than 94% within 1 
week (Fig. 1B). Concomitantly, the prothrombinase activ- 
ity measured in presence of the erythrocytes increased 
slightly (Fig. 1A), and the cells became more susceptible 
to hemolysis (Fig. 1C). However, even with cells stored 
for up to 3 weeks, the prothrombinase activity did not 
exceed a level that corresponded to an estimated fraction 
of 0.3% PS in the outer monolayer. This showed that 
phospholipid asymmetry is quite stabile at this low temper- 
ature in absence of ATP. 
When vanadate was present during storage, the pro- 
thrombinase activity in presence of cells increased rapidly 
(Fig. 1A). During 3 weeks of storage PS exposure in- 
creased by a factor of 50 to reach approximately 2%. In 
this case, ATP was also consumed more rapidly than 
during storage without vanadate (Fig. 1B), and the cells 
were more fragile (Fig. 1C). 
Because of experimental restrictions (low cell concen- 
tration) it was not possible to determine hemolysis after 
having performed the prothrombinase assay. Therefore, 
hemolysis as measured in the cell suspension (see Section 
2) has to be interpreted as an increasing susceptibility of 
the cells to damage by sample handling, rather than the 
exact number of leaky cells in the prothrombinase assay 
medium. Thus, it can not be excluded that the increase in 
prothrombinase activity observed in Fig. 1A is due to 
exposure of PS located at the inner monolayer of lysed 
Table 1 
Prothrombinase activities obtained with regular erythrocytes, neu- 
raminidase-treated c lls, and with low- and high-ATP DMPC-induced 
vesicles directly after preparation 
Membrane system Prothrombinase activity n 
(rim thrombin/ 
min-/zM PL) 
erythrocytes 1.06 -[- 0.54 12 
erythrocytes, 1.47 a 1 
neuraminidase tr ated 
Iow-ATP vesicles 19.6 +__ 4.7 6 
high-ATP vesicles 31.9 + 10.7 5 
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Fig. 1. Prothrombinase activity, ATP-content and cell fragility of red 
blood cells during storage. Erythrocytes were stored at 6°C in presence of
deoxyglucose in absence (circles) and presence (triangles) of 2.5 mM 
vanadate as described in Section 2. Determinations of prothrombinase 
activity, ATP-content and hemolysis were performed at the indicated 
times. The results hown are data from one experiment with blood from 
one donor. The experiment was reproduced 3 times with different blood 
specimens. Because of variation in initial values (prothrombinase ctivity 
0.36 to 0.85 nM thrombin/min./xM PL, ATP-content 42 to 61 /xM/mM 
hemoglobin) the data were not included in the figures. However, for each 
blood sample, the curves displayed the same characteristic dependence 
with time. Data points without apparent error bars reflect counting errors 
less than the size of the data symbols. Panel A: prothrombinase ctivity 
per /xM phospholipid. The vertical bars indicate the S.D. in repeated 
(n = 3) measurements of the same specimen. Panel B: ATP-content of the 
cells per mM hemoglobin (duplicate measurements). Panel C: percentage 
of spontaneously hemolysed cells. 
cells, even though there is no direct quantitative correlation 
between the patterns of cell fragility (Fig. 1C) and pro- 
thrombinase activity (Fig. 1A). As deduced from the assay 
performed with completely hemolyzed cells (see Section 
2) each percent of hemolysis would enhance the prothrom- 
binase activity only by approximately 0.85 nM/min  •/.tM 
PL, which is significantly lower than the increase in 
activity shown in Fig. 1A. 
Data for erythrocytes and low ATP vesicles were in part published in [8]. 
Values are given as mean f: standard error, n is the number of different 
cell or vesicle populations. 
a The concomitant value for untreated cells of the same blood population 
was 1.62 nM/min ./xM PL. 
3.3. Storage of DMPC-induced vesicles 
During 22 days of storage at 6°C the prothrombinase 
activity in presence of Iow-ATP vesicles (Fig. 2A) in- 
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Fig. 2. Prothrombinase activity in presence of DMPC-induced vesicles during storage. DMPC-induced vesicles were prepared from either regular 
erythrocytes with an ATP-level of 65 /~M/mM hemoglobin (Iow-ATP vesicles), or from cells with an increased ATP-level of 184 ,~M/mM hemoglobin 
(high-ATP vesicles), and stored at 6°C. Panel A shows the prothrombinase activity in presence of low-ATP vesicles upon storage in absence (circles) and 
presence (triangles) of 2.5 mM vanadate. Panel B shows the same in presence of high-ATP vesicles. The results presented are data from one experiment 
representative of 4 storage xperiments with different blood specimens in absence of vanadate. The experiment in presence of vanadate was reproduced 
once with a different vesicle specimen in presence of 1 mM vanadate, with consistent results. Because of variation in the initial values (14.2 to 45.2 nM 
thrombin/min •/~M PL), the data from the other experiments could not be included in the figures. However, for each vesicle preparation the curves 
indicated the same characteristic dependence with time. The vertical bars indicated in the figures represent the variation between triplicate measurements of 
the same specimen. Data points without apparent error bars reflect counting errors less than the size of the data symbols. A change in symbol filling 
indicates an in-between purification of the vesicles as described in Section 2. 
creased by a factor of 5, which reflected an estimated final 
distribution of 5% PS exposed on the outside. The ATP- 
level, as shown in Fig. 3A, had decreased at this point to 
15% of the ATP-content of freshly prepared Iow-ATP 
vesicles, which corresponded to a level of less than 5% of 
the ATP-content of regular erythrocytes. 
In presence of high-ATP vesicles the prothrombinase 
activity was in a similar range as the activity in presence 
80 
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storage t ime (days) 
Fig. 3. ATP-depletion during storage of DMPC-induced vesicles. Panel A shows the ATP-content of low-ATP vesicles upon storage in absence (circles) 
and presence (triangles) of 2.5 mM vanadate. Panel B shows the same for high-ATP vesicles. The results shown are data from one representative 
experiment (same blood specimen as in Fig. 2) of 4 storage xperiments with different blood specimens in absence of vanadate. The experiment in
presence of vanadate was reproduced once in presence of 1 mM vanadate, which showed a slightly lower ATP-hydrolysis rate. Because of variation in the 
initial values (ATP-content of Iow-ATP vesicles 6.9 to 18.0 gM/mM hemoglobin, of high-ATP vesicles 51.6 to 95.3 /.LM/mM hemoglobin), the data 
from the other experiments were not included in the figures. However, for each vesicle specimen the curves showed the same characteristic dependence 
with time. 
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of low-ATP vesicles when both populations were mea- 
sured directly after the preparation (see Table 1). However, 
as shown in Fig. 2B, an 18-fold increase in prothrombinase 
activity was seen after 22 days, in spite of the fact that the 
ATP-level of this system (Fig. 3B) was 4 times higher than 
that of the low-ATP vesicles. This shows that the pro- 
thrombinase activity in presence of the vesicles does not 
correlate to their ATP-content. According to our estimation 
approximately 20% PS was found on the outside of the 
high-ATP vesicles after 22 days. 
3.4. Storage of  DMPC-induced vesicles in presence o f  
vanadate 
To obtain information on the influence of vanadate on 
the vesiculation process, both low- and high-ATP vesicles 
were prepared in presence of 1 mM vanadate. The time 
dependence and quantity of vesicle release, monitored by 
AChE-activity, was not altered. The presence of vanadate 
during the vesiculation process did not influence the ATP 
content of the released vesicles, and the composition of the 
obtained vesicles with respect o phospholipid and protein 
content was not different from normal DMPC-induced 
vesicles (data not shown). On the other hand, in high-ATP 
vesicles the initial velocity of translocation as measured 
with a spin-labelled PS-analogue (according to [15]) was 
inhibited by 75%, independent of the time point of addi- 
tion of vanadate (data not shown). Based upon these 
observations, vesicles were prepared without vanadate (as 
described above) and subsequently stored in presence of 
2.5 mM vanadate. 
With Iow-ATP vesicles stored in presence of vanadate, 
the prothrombinase activity (Fig. 2A) was approximately 
20% higher than in absence of vanadate. After 22 days of 
storage, 6% PS was estimated to be located in the outer 
monolayer. On the other hand, in presence of high-ATP 
vesicles a much more pronounced effect of vanadate was 
observed (Fig. 2B) with a 2-fold increase in activity com- 
pared to storage without vanadate, leading to exposure of 
approximately 40% of the total PS-pool after 22 days. 
Furthermore, in both types of vesicles this was accompa- 
nied by a more rapid loss of ATP (Fig. 3). 
A parallel investigation of vesicle membrane asymme- 
try with phospholipase A 2 turned out to be unreliable, 
because the high-ATP vesicles immediately lysed upon 
treatment with the enzyme, suggesting a decreased mem- 
brane stability. 
3.5. Vesicle integrity during storage 
In the high-ATP vesicle preparations the fraction of 
leaky vesicles was always higher than in the low-ATP 
preparations, indicating that the high-ATP vesicles were 
more fragile (Fig. 4). This fragility was markedly in- 
creased in presence of vanadate. To make sure that in- 
creased prothrombinase activity was not due to exposure 
of PS in lysed vesicles, high-ATP vesicles were subjected 
to several purification steps during the storage period. A 
comparison of Fig. 2B with Fig. 4B shows that a marked 
reduction of the fraction of leaky vesicles after purification 
(indicated by a change in symbol filling) did not result in a 
concomitant reduction of the prothrombinase activity, indi- 
i ~ i i I i i i i i 
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Fig. 4. Adenylate kinase index of DMPC-induced vesicles during storage. Values are expressed asthe percent ratio of adenylate kinase activity in absence 
and in presence ofTriton X-100. Panel A shows the integrity of Iow-ATP vesicles during storage inabsence (circles) and presence (triangles) of 2.5 mM 
vanadate. Panel B shows the same for high-ATP vesicles. The results hown are data from one storage xperiment (same blood specimen as in Fig. 2 and 
3) representative of 4experiments with different blood specimens in absence of vanadate. The experiment i  presence ofvanadate was reproduced once in 
presence of 1 mM vanadate, with consistent results. A change in symbol filling indicates an in-between purification of the vesicles as described under 
Section 2. 
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Fig. 5. SDS-polyacrylamide g l electrophoresis of the proteins from red 
cell membranes, vesicles, and isolated vesicle membranes. Proteins were 
stained with Coomassie blue. Subsequent silver staining did not reveal 
any further differences between the vesicle types (data not shown). Lane 
A: red cell membranes; lane B: delipidified low-ATP vesicle membranes; 
lane C: delipidified high-ATP vesicle membranes; lane D: Iow-ATP 
vesicles; lane E: high-ATP vesicles. The fractions were prepared as 
described under Section 2. The outer lanes show molecular weight 
standards (94, 67, 43, 30, 20.1, and 14.4 kDa). 
cating that this activity is not correlated to leakiness of the 
vesicles (at least below the level of 10% leaky vesicles). 
3.6. Protein compositions 
SDS-polyacrylamide g l electrophoresis of the protein 
of membranes i olated from DMPC-induced vesicles, as 
depicted in Fig. 5, showed that vesicle membranes contain 
the main intrinsic membrane proteins of the red cell mem- 
brane. On the other hand, spectrin was completely lacking 
and other peripheral (skeleton) proteins such as band 4.1 
were partly absent. This confirms previous studies per- 
formed with intact vesicles, and, furthermore, demonstrates 
that both high- and low-ATP vesicles show the same 
membrane protein composition, which in turn suggests that 
protein composition can not be the reason for the increased 
fragility of the high-ATP vesicles. 
4. Discussion 
The rate of conversion of prothrombin to thrombin by 
the enzyme complex factor Xa-factor Va has been widely 
used as a convenient, rapid, and sensitive method to 
monitor in a semiquantitative way the extent of exposure 
of PS at the cell surface [8,17,25,26]. By this method the 
fraction of PS at the outer monolayer of erythrocyte mem- 
branes was estimated to be less than 0.1% under normal 
conditions (see Table 1, and [8]). No increase in prothrom- 
binase activity was observed in presence of neuraminidase 
treated cells, indicating that the very low activity in pres- 
ence of the cells is not due to reduced accessibility of the 
phospholipid surface to the factors of the prothrombinase 
complex, through shielding by sialic acid residues. 
Several studies have reported that phospholipid asym- 
metry is not immediately ost upon ATP-depletion [9-11], 
or during prolonged storage of red blood cells [12]. In the 
present study, it is accordingly shown that PS asymmetry 
is relatively stabile during storage of the cells at 6°C in 
presence of deoxyglucose, ven when ATP-depletion is 
complete. The maximum fraction of PS exposed to the 
outside after 3 weeks of storage was 0.3%, which is 
definitely too low to be recognized by conventional tech- 
niques, like by the assay with phospholipase A 2 [12]. 
Increasing cell fragility, reflected by enhanced spontaneous 
hemolysis, might have lead to the slight increase in pro- 
thrombinase activity observed uring the storage time (Fig. 
1C). This suggests that ATP-depletion induces secondary 
events that affect cell fragility, rather than that it has a 
direct effect on phospholipid redistribution. Indeed, the 
intracellular level of ATP influences the degree of 
phosphorylation f membrane skeletal proteins, which has 
been suggested to alter the stability of the membrane [27]. 
Apart from ATP-depletion, several abnormalities have been 
reported to occur in red cells during in vitro storage, 
presumably due to oxidative damage [28]. 
In presence of low-ATP DMPC-induced vesicles the 
prothrombinase activity is significantly higher than the 
activity in presence of the cells they are derived from, even 
though the distribution of PS is still highly asymmetric [8]. 
As stated before, treatment of the cells with neuraminidase 
has revealed that this difference is probably not due to 
increased accessibility of the vesicle phospholipid bilayer 
to the enzymes of the prothrombinase complex. 
The observed enhanced exposure of PS on the outer 
monolayer of the vesicles has to arise in the relatively 
short period of approximately 5 h that pass between the 
onset of vesicle release and the first assay. Spontaneous 
outward movement (flop) of spin-labelled PS analogues in 
presence of Mg-ATP has been reported to have a half-time 
of 1 h at 37°C [29], but with synthetic dilauroyl-PS this 
was reported to be 15 h [30]. In analogy to phosphatidyl- 
choline-flop [31 ], PS-flop is likely to be dependent on acyl 
chain length, thus slower with the endogenous long fatty 
acyl chain phospholipids. Moreover, the temperature has 
not exceeded 30°C during preparation and purification of 
the vesicles. Thus, the observed redistribution can hardly 
be attributed to spontaneous outward movement of PS 
alone. 
As discussed before in the same context [8], increased 
transbilayer movement of the phospholipids could have 
occurred at fusion sites during vesicle budding [2,32,33]. 
Our present results however, do not support his model. In 
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the first place, asymmetry would have been restored more 
efficiently in the high-ATP vesicles because of the higher 
aminophospholipid translocase activity in these vesicles 
[15], whereas low- and high-ATP vesicles showed similar 
initial prothrombinase activities (see Table 1), which were 
dependent on the blood specimen they were derived from, 
rather than on the ATP-content (unpublished observations). 
Moreover, the presence of vanadate during the preparation 
of vesicles did not influence the vesiculation process and 
the phospholipid istribution in the vesicle membranes, 
since the initial prothrombinase activities were similar in 
presence and absence of vanadate, showing that the 
aminophospholipid translocase does not play a role in the 
vesiculation process. 
A more likely explanation for the observed loss of 
asymmetry is therefore, that structural differences between 
cells and vesicles are responsible for the new steady-state 
transbilayer distribution in the vesicles. As discussed ear- 
lier in this context [8], increased accessibility of PS in the 
vesicles to the enzymes of the prothrombinase complex 
might have originated from an increased transbilayer mo- 
bility induced by the slightly changed lipid composition of 
the vesicle membrane [34], from a difference in the ratio 
outer versus inner monolayer due to curvature of the 
membrane, or from a difference in relative membrane 
surface versus total phospholipid content, which affects the 
PS-density [26]. Also, it can not be excluded at present, 
that the absence of an intact membrane skeleton is respon- 
sible for the observed ifference in PS-asymmetry between 
vesicles and red blood cells [4,35]. 
Once the new steady-state situation is established, the 
low-ATP vesicle asymmetry remains fairly stabile. The 
prothrombinase activity in presence of Iow-ATP vesicles 
after 22 days of storage reflected a still highly asymmetric 
distribution of PS (estimated maximally 5% outside). Be- 
cause DMPC-induced vesicles lack the capability of regen- 
erating ATP [15], storage is accompanied by loss of ATP, 
independent of the amount of nutrients in the storage 
medium. The final ATP-level after 22 days of storage was 
below 5% of the normal ATP-content of erythrocytes, 
which is not sufficient for full activity of the aminophos- 
pholipid translocase [2]. 
Paradoxically, the high-ATP vesicles lost their PS- 
asymmetry 3 to 4 times more rapidly than the low-ATP 
vesicles, although the ATP-level in this system was ap- 
proximately 4 times higher during the entire storage period 
(Fig. 3). This controversial relation between the (re)distri- 
bution of PS and the ATP-content of the vesicles uggests 
that other mechanisms than the aminophospholipid translo- 
case play a role in maintaining phospholipid asymmetry. 
It has been reported [31,36] that in a bilayer system 
consisting of long acyl chain phospholipids in presence of 
cholesterol, spontaneous transbilayer diffusion is very slow. 
This would be able to explain the extreme stability ob- 
served in the low-ATP vesicles during storage at low 
temperature. However, this does not explain the observed 
loss of PS-asymmetry in the high-ATP vesicles, since there 
are no apparent structural differences between the two 
types of vesicles, neither in phospholipid composition, or 
in cholesterol to phospholipid ratio (unpublished observa- 
tions) or in protein composition (Fig. 5). This means that 
the same structure is disturbed in case of the high-ATP 
vesicles, but not in Iow-ATP vesicles, or in red blood cells 
where asymmetry is more efficiently maintained. An influ- 
ence of the membrane skeleton can be excluded in this 
case, since this is not present anymore in the DMPC-in- 
duced vesicles. 
Aminophospholipid transport has been suggested to be 
bi-directional, with the outward movement also being de- 
pendent on ATP [29,37]. However, with such an ATP-de- 
pendence, the rate of PS outward movement would actu- 
ally decrease when more ATP has been consumed. There- 
fore such a mechanism can not be the basis of our findings 
(Figs. 2 and 3), since PS exposure in both types of vesicles 
increases progressively with time and does not appear to 
be dependent on ATP concentrations. 
Another mechanism that has been shown to induce 
scrambling of phospholipids, is increasing the intracellular 
Ca 2+ concentration to millimolar levels [38], provided that 
the aminophospholipid translocase and the Ca2+-pump are 
inhibited. Since the prothrombinase assay medium contains 
4 mM Ca 2 +, it can not be excluded from our experiments 
that increased permeability o this ion, leading to a sudden 
rise in the intemal Ca 2+ concentration during the assay, 
might have induced the observed loss of PS asymmetry in
the vesicles. However, Ca2+-induced scrambling has been 
reported to take 1 h to complete in erythrocytes [32,38,39], 
whereas in our experiments the prothrombinase activity 
expressed per minute was independent of the time interval 
of measurement upto 3 min (data not shown). This implies 
that either scrambling of the vesicle phospholipids was 
completed within the 2 min of preincubation i CaZ+-con - 
taining buffer, or that Ca 2 + internalization simply has not 
occurred. 
Even when asymmetry would be lost due to the pres- 
ence of Ca 2÷ in the assay rather than to a defect initiated 
upon storage of the vesicles, it is not clear what mecha- 
nism would have made high-ATP vesicles more fragile 
and thus more permeable to Ca 2÷ than Iow-ATP vesicles. 
In particular, removal of that fraction of vesicles that were 
known to be leaky did not lead to a decrease in prothrom- 
binase activity (compare Fig. 2B and 4B), implying that 
even in presence of the population of permeable vesicles 
the prothrombinase activity was not increased. Moreover, 
it could be expected that both the Ca2+-pump and 
aminophospholipid translocase are more active in high-ATP 
vesicles, making them better able to maintain low internal 
Ca a+ concentrations and to restore membrane asymmetry, 
which is clearly not the case. Sulpice et al. [40] have 
proposed that the presence of PIP 2 in the membrane is 
correlated to Ca2--induced scrambling, what would agree 
with the content of this phosphorylated lipid being higher 
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in high-ATP vesicles, thereby inducing more scrambling, 
whereas it would be diminished in the low-ATP vesicles. 
However, as earlier mentioned, high-ATP vesicles lose 
their ATP content during storage, what would accordingly 
result in a decrease in PIP 2 content [40], and thus a 
decrease in the ability to scramble. Since scrambling con- 
tinuously increased with time of storage (Fig. 1B), any 
mechanism related to the transiently increased presence of 
a phosphorylated compound can not agree with our results. 
The loss of asymmetry observed in presence of vana- 
date in low-ATP vesicles and even more pronounced in 
high-ATP vesicles (Fig. 2), as well as in red blood cells 
(Fig. 1A), might be attributed to an inhibition of the 
aminophospholipid translocase. However, here again, it 
should be expected that with decreasing ATP-content of 
the vesicles the effect of vanadate decreases, since in a 
situation of ATP depletion the contribution of the translo- 
case to maintaining asymmetry is diminished as well. Yet, 
the scrambling effect of vanadate did not decrease upon 
prolonged storage, even though ATP was actually hydrol- 
ysed much more rapidly. Therefore, a direct perturbing 
effect of vanadate on membrane asymmetry has to be 
considered. This would be in line with an observation of 
Bitbol et al. [16] who have proposed that, after reduction 
of vanadate to vanadyl [41], this ion interacts directly with 
the phospholipids. Since the intracellular eduction of 
vanadate is related to processes that require energy, this 
might also explain the enhanced ATP decrease in presence 
of vanadate [41 ]. 
A valid explanation for the different behaviors of the 
two vesicle populations can not be provided yet. Several 
ATP-dependent processes may contribute, such as the 
modulation of either protein and lipid phosphorylation [42] 
or transmembrane pH or ion gradients [43,44]. Further 
investigations will have to reveal the exact nature of the 
underlying phenomenon. 
In conclusion, we have shown that the asymmetric 
distribution of PS is well preserved in low-ATP DMPC-in- 
duced vesicles, in spite of the fact that these membrane 
vesicles do not contain an intact membrane skeleton, and 
under conditions where the aminophospholipid translocase 
is not able to contribute to PS inward transport. Moreover, 
in identical vesicles with an elevated ATP-content PS- 
asymmetry is perturbed more rapidly, which indicates that 
this phospholipid redistribution is independent of ATP and 
membrane composition. We therefore postulate that other 
mechanisms must be involved in maintaining phospholipid 
asymmetry. 
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